Skip to main navigation Skip to search Skip to main content

Deep brain stimulation for the treatment of resistant hypertension

  • Erin L O'Callaghan
  • , Fiona D McBryde
  • , Amy E Burchell
  • , Laura E K Ratcliffe
  • , Liviu Nicolae
  • , Ivor Gillbe
  • , Derek Carr
  • , Emma C Hart
  • , Angus K Nightingale
  • , Nikunj K Patel
  • , Julian F R Paton

Research output: Contribution to journal › Article (Academic Journal) › peer-review

32 Citations (Scopus)

Abstract

Hypertension is a leading risk factor for the development of several cardiovascular diseases. As the global prevalence of hypertension increases, so too has the recognition of resistant hypertension. Whilst figures vary, the proportion of hypertensive patients that are resistant to multiple drug therapies have been reported to be as high as 16.4 %. Resistant hypertension is typically associated with elevated sympathetic activity and abnormal homeostatic reflex control and is termed neurogenic hypertension because of its presumed central autonomic nervous system origin. This resistance to conventional pharmacological treatment has stimulated a plethora of medical devices to be investigated for use in hypertension, with varying degrees of success. In this review, we discuss a new therapy for drug-resistant hypertension, deep brain stimulation. The utility of deep brain stimulation in resistant hypertension was first discovered in patients with concurrent neuropathic pain, where it lowered blood pressure and improved baroreflex sensitivity. The most promising central target for stimulation is the ventrolateral periaqueductal gray, which has been well characterised in animal studies as a control centre for autonomic outflow. In this review, we will discuss the promise and potential mechanisms of deep brain stimulation in the treatment of severe, resistant hypertension.

Original languageEnglish
Pages (from-to)493
JournalCurrent Hypertension Reports
Volume16
Issue number11
DOIs
Publication statusPublished - Nov 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Groups and Themes

  • CRICBristol

Fingerprint

Dive into the research topics of 'Deep brain stimulation for the treatment of resistant hypertension'. Together they form a unique fingerprint.

Cite this